Treatment Registry
TR-0575 ActiveRecorded September 2026

Compounded tirzepatide

Sold by Fierce Health · Injection, vial · every compounded tirzepatide record

Recorded initial charges

First month

$497

first month, including required fees on record. The published monthly rate excludes one-time and annual fees; introductory and conditional rates may change. Some fee details are unverified or unpublished; this sum does not establish the full amount payable.

Medication · Full-dose Tirzepatide Weight Loss Program, monthly · recorded initial monthly payment$497

Added from the figures recorded below.

Price

TermPer monthCharged today
Full-dose Tirzepatide Weight Loss Program, monthly

“Tirzepatide Weight Loss Program Regular price $497.00 Sale price $497.00”

Per month$497Charged today$497
Price sources
Visit Fierce Health

We earn nothing from this link. It opens Fierce Health's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • September 2026 — Entry added to the register

Sourcing and terms

PrescriberBoth
CancellationThis is a subscription, not a one-time purchase. Your plan renews automatically on the schedule you choose, so your medication and support arrive each cycle without a gap. You are always in control and can cancel anytime under our cancellation policy.

Not yet checked: pharmacy, states, membership and consult fee.

Recorded from fiercehealth.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2026 — The product pages contradict each other on state coverage: the main semaglutide and tirzepatide program pages both claim 'delivered to all 50 states,' but the semaglutide MICRODOSE page (same domain, same day) instead says 'We ship to most U.S. states, if we can't ship to you, you will be refunded' -- an outright contradiction, so states.kind is recorded as not-found rather than all-50. The tirzepatide product page also has a copy-paste error describing its own vial as 'Compounded semaglutide from a licensed pharmacy' in one paragraph even though the page title and drug name are Tirzepatide.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0575
Medication category
compounded tirzepatide
Readings
1

Related records

Other records from Fierce Health

All Fierce Health programs and terms

Compounded tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 374 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Fierce Health — compounded tirzepatide (TR-0575). Last verified September 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0575

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.